LifeStance CMO files initial Form 3

LifeStance Health Group, Inc. insider Stephanie Carin Eken, the company’s Chief Medical Officer, filed an initial ownership report on Form 3.

Accepted by SEC EDGAR 02/24/2026 - 07:19 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

LifeStance Health Group, Inc. insider Stephanie Carin Eken, the company’s Chief Medical Officer, filed an initial ownership report on Form 3. This filing formally records her status as an executive officer of LifeStance Health but does not list any specific share transactions or holdings in the excerpt provided.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the LifeStance Health (LFST) Form 3 filing by Stephanie Carin Eken show?

The Form 3 filing shows that Stephanie Carin Eken is a reporting person as Chief Medical Officer of LifeStance Health Group, Inc.. It is an initial statement of beneficial ownership and, in this excerpt, does not detail specific share amounts or transactions.

Who is the insider named in LifeStance Health (LFST) Form 3?

The insider is Stephanie Carin Eken, who serves as Chief Medical Officer of LifeStance Health Group, Inc. The filing identifies her as an officer but, in the available data, does not show any buy, sell, acquire, or dispose transactions in company stock.

Does the LifeStance Health (LFST) Form 3 for Stephanie Eken report any stock transactions?

No, the provided Form 3 data for Stephanie Carin Eken shows zero buys, sells, acquisitions, or dispositions. The transaction summary indicates no share activity, meaning this filing primarily serves to establish her insider status at LifeStance Health Group, Inc.

What role does Stephanie Carin Eken hold at LifeStance Health (LFST) in this Form 3?

In this Form 3, Stephanie Carin Eken is listed as an officer of LifeStance Health Group, Inc. with the title Chief Medical Officer. The filing focuses on her status as a reporting person rather than outlining any particular equity awards or trades.

Why is a Form 3 filed for LifeStance Health (LFST) Chief Medical Officer Stephanie Eken?

Form 3 is filed to identify Stephanie Carin Eken as an insider of LifeStance Health Group, Inc. in her role as Chief Medical Officer. It is an initial ownership report; the excerpted data does not include specific share counts or transaction details.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Eken Stephanie Carin

(Last) (First) (Middle)

C/O LIFESTANCE HEALTH GROUP, INC.

4800 N. SCOTTSDALE ROAD, SUITE 2500

(Street)

SCOTTSDALE AZ 85251

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
02/16/2026

3. Issuer Name and Ticker or Trading Symbol
LifeStance Health Group, Inc. [ LFST ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Medical Officer

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney

No securities are beneficially owned.

	/s/ Ryan Pardo, Attorney-in-Fact	02/24/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.